© All-Russian National Academy of Mycology, 2001
© A. Sergeev, 1999-2001

  First SCIO trial: results
  In group 1, the clinical cure at endpoint was achieved in 36 patients (78,26 %). In group 2 the clinical cure at endpoint was achieved in 43 patients (82,69 %). The clinical cure was in all cases accompanied by negative KOH microscopy.

This chart illustrates clinical cure rates of terbinafine (blue) and itraconazole (pink) in relation to baseline SCIO in compared groups.

In this trial the correlation between baseline SCIO and cure rate was significant with p < 0,01.
 
   
 
 
 
Home The concept of SCIO What SCIO
is made of?
How to use SCIO? SCIO utilities Questions
and answers